Drugmakers Cut Prices 61% to Get on Coveted China List

(Bloomberg) -- Drugmakers including AstraZeneca Plc and Roche Holding AG agreed to cut prices of some of their newest innovative drugs in China by an average of 61% as the government expanded the n...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.